Moderna
-
Moderna COVID-19 Vaccine: 2nd FDA Approval for Shot After Pfizer; Booster Shot for Approval Too?
-
Moderna’s COVID-19 Booster to Produce 2nd Shot, But Experts Doubt its Need Now; Shorter Waiting Time for Jab
-
Moderna Research Shows Difficulty in mRNA Flu Vaccine Creation, ‘Not a Silver Bullet’
-
Global Stock Markets Fall After Moderna Boss Said COVID Vaccines Won't be as Effective Against Omicron Variant
-
Moderna to Make COVID-19 Vaccines Against Omicron Variant! CMO Says Expect Fast Production and 2022 Arrival
-
Pfizer, Moderna to ‘Update’ Vaccines to Work Against New Extremely Infectious Variants, WHO Warns
-
Edible Vaccine? Researchers Aim to Put mRNA Components from Pfizer, Moderna in Plants
-
Moderna mRNA HIV Vaccine is Set for its Phase 1 Experimental Test, For those Without the Virus
-
Capacity Partners With Citeline Connect for Moderna Clinical Trial Recruitment Site
-
COVID-19 Vaccine for Children Ages 5 to 11 Years Old May Come Soon from Manufacturers, as Requested by the FDA—Is it Safe?
-
COVID-19 Study Shows That Those Who Had Allergic Reactions to 1st Shot of mRNA Vaccines Can Get 2nd Dose
-
Johnson & Johnson's COVID-19 Vaccine Protects Less Against the Delta Variant; Experts, CDC Claim
Most Popular
